Paramedic Drug Card

Initial: 6 mg rapid IV push with 20 ml saline flush. Repeat at 1-2 mins at 12mg up to 2 times if no effect Peds: Safety not established

• Nebulizer: 2.5 mg diluted to 2.5 ml over 15 minutes.
• MDI: 1-2 puffs (90 μg/spray)
• Peds: 0.15 mg/kg (0.03 ml/kg diluted to 2.5 ml in nebulizer

Load with 5 mg/kg IV/IO slowly over a 20 to 30-minute period, followed by an infusion. An infusion rate of 0.4 mg/kg/hr is effective for a nonsmoker, but a patient who smokes can require a high infusion rate at 0.8 mg/kg/hr IV/IO. When treating patients with CHF, reduce the dose to 0.2 mg/kg/hr

• VT with pulse: 150mg over 10 minutes, 15mg/min, either by infusion or bolus
• VT/VF 300mg IV push may repeat at 3-5 minutes at 150mg IV push if no change. Maintenance drip is 1mg/min for first 6 hrs then 0.5mg/min thereafter; Peds: 5mg/kg IV or IO
• VT with Pulse 2.2 g over 24 hours
• VT/VF 450 mg

• 325mg PO once.
• Not recommended for Peds

5 mg IV/IO over a 5-minute period; repeat in 5 minutes

• Indication : Symptomatic bradycardia - except second degree type 2 and third degree blocks
• 0.5 mg q 3-5 min rapid IV/IO push

• Indication : Organophosphate Poisoning
• 3-5 mg every 3-5 minutes until secretions dry; doses of 100 mg have been reported

2-4mg/kg of a 10% solution slow IV push q 10 minutes

500 to 1000 mg IV, IO administered slowly at a rate of approximately 1 to 1.5 mol/min

• 4-24mg IM, IV, IO;
• Peds: 0.2-0.4mg/kg

• Adult: 25g IV push
• Peds: 0.5g/kg dilute 1:1 to form 25% solution.
• Neonates: receive 10% solution

• Status epilepticus 5-10 mg slow IV/IO
• Anxiety 2-5mg slow IV /IO or IM and
• Premedication 5-15 mg IV/IO
• Peds: 0.1-0.2mg/kg for status epilepticus IV/IO or rectal

0.25mg/kg actual body wt. IV/IO over 2 minutes (20mg avg. person)

• Adult: 25-50mg slow IV/IO or IM;
• Peds: 1-2mg/kg slow IV/IO to a max of 50 mg

• Low: 2-5 mcg/kg/min;
• Medium: 5-10 mcg/kg/min; High: 10-20 mcg/kg/min.
• Bradycardia (AHA): 2-10 mcg/kg/min

• Indication: Asthma/ Anaphylaxis
• Adult: 0.3-0.5 mg IM/SQ;
• Peds: 0.01mg/kg IM/SQ

• Indication: All Cardiac Arrests: PEA, VT/VF without a pulse and Asystole
• Adult: 1mg q 3-5 minutes for life of code IV or IO.
• Peds: 0.01mg/kg q3-5 minutes

• Indication: Asthma/ Anaphylaxis
• Adult: 0.1 mg IV/ IO;
• Peds: 0.01mg/kg IV/IO.

• Indication: Bradycardia refractory to TCP, atropine and dopamine
• 2-10mcg/min continuous IV Infusion (mix 1mg in 250 ml D5W) Titrate to effect.

25–50 mcg IV/IM/IN q 2 minutes PRN

Initial dose is 0.2 mg IV, IO over a 15-second period. If the desired effect is not observed after 45 seconds, administer a second 0.2-mg dose, again over a 15-second period. Doses can be repeated a total of four times until a total dose of 1 mg has been administered

• Adult: 0.5-1.0 mg/kg or match pt. single PO dose;
• Peds: 1mg/kg

• Indication: Hypoglycemia when IV line is not available
• 1.0mg Deep IM if > 20kg 0.5mg if < 20kg

• Indication: Beta blocker or calcium channel blocker overdose
• 2-5mg Iv/IO over a 1-minutes period followed by a second dose of 10 mg IV if the symptoms of bradycardia and hypotension recur.

500mcg added to small volume nebulizer along with first dose of bronchodilator

1-4.5 mg/kg IV/IO; 6.5-13 mg/kg IM

15-30mg IV or 30-60mg IM

• Adults: MDI 2 sprays;
• Nebulizer - 0.63 mg, repeat prn.

• Pediatric: MDI 1 spray;
• Nebulizer - 0.63 mg repeat prn.

Cardiac Indications: 10 mg IV, IO over a 1- to 2-minute period. May repeat every 10 minutes to a maximum dose of 150 mg or give initial bolus and then follow with infusion at 2 to 8 mg/min; Severe Hypertension: Initial dose is 20 mg IV, IO slow infusion over a 2-minute period. After the initial dose, blood pressure should be checked every 5 minutes. Repeat doses can be given at 10-minute intervals. The second dose should be 40 mg IV, IO, and subsequent doses should be 80 mg IV, IO, to a maximum total dose of 300 mg. The effect on blood pressure typically will occur within 5 minutes from the time of administration. Alternatively, may be administered via IV infusion at 2 mg/min to a total maximum dose of 300 mg

Analgesia and Sedation: Adult: 2 mg or 0.44 mg/kg IV, IO, whichever is smaller; Pediatric: 0.05 mg/kg IV, IO. Each dose should not exceed 2 mg IV, IO; Seizures: Adult: 4 mg IV, IO given over 2 to 5 minutes; may repeat in 10 to 15 minutes (max total dose: 8 mg in a 12-hour period); Pediatric: Adolescents: 0.07 mg/kg slow IV, IO given over 2 to 5 minutes (max single dose: 4 mg). May repeat in 10 to 15 minutes (max dose: 8 mg in a 12-hour period); Children and infants: 0.1 mg/kg slow IV, IO given over 2 to 5 minutes (max single dose: 4 mg). May repeat at half the original dose in 10 to 15 minutes if seizure activity resumes; Neonates: 0.05 mg/kg slow IV, IO given over 2 to 5 minutes. May repeat in 10 to 15 minutes

1-1.5mg/kg IV push

2-4mg/min IV drip (dose dependant on amount of lidocaine used in initial IV bolus)

• Indication: Wide complex lethal rhythms such as V-Tach and V-Fib / Torsade de pointes
• VF/Pulseless VT: 1-2g IV over 2 min; Torsades: 5-10 g IV at 1g/min until rhythm is suppressed

• Indication: Bronchospasm, asthma
• Adult: 1-2 g IV over 30 minutes.
• PEDS: 75 mg/kg over 30 minutes up to adult dose.

• Indication: Toxemia (seizures of pregnancy)
• 1-4g IV, IM

• Adult: 50 to 150 mg IV, IO, IM, or Sub-Q.
• Elderly: 50 mg IV, IO, IM, or Sub-Q;
• Peds: 1 to 2 mg/kg IV, IO, IM, or Sub-Q

125-250mg IV, IM

5 mg IV q 5 min

• Indication: Status epilepticus
• Adult: 2.5mg increments up to a total of 10mg IV, IO, IM or IN. Must be diluted before IV Use
• Ped: 0.03mg/kg

• Indication: Chemical Restraint and sedation for cardioversion
• 2.-2.5mg IM or IN

2-10mg IV q 3-5 min in 2mg increments (titrate to effect)

0.4mg to 2mg IV, IO, IN and 2 x dose ET diluted in 10 ml titrate to relief of respiratory depression

0.4mg sl q 3-5minutes

1/2-1 inch applied to anterior chest wall

8-12 mcg/min IV/IO infusion titrate to effect; maintenance drip 2-4 mcg/min

5-10mcg/min on IV Pump only

4 mg IV/IM; may repeat in 10 minutes if necessary

• Adult: 12.5-25mg IV/IM/IO
• Peds: 0.5mg/kg

• Adult: 1 to 3 mg IV, IO at a rate of 1 mg/min; may repeat the dose 2 minutes later;
• Peds: 0.01 to 0.1 mg/kg slow IV, IO over a 10-minute period

0.25-0.75 ml of a 2.25% solution in 2ml NaCl Nebulizer

1meq/kg IV/IO push initial repeat doses at 0.5meq/kg q 10 minutes

• Wernicke-Korsakoff Syndrome: 100 mg IV/IO;
• Peds: Not recommended for pediatric patients

40 units IV/IO push

2.5-5mg slow IV push repeat dose at 15 -30 minutes of 5-10mg slow IV push